STOCKHOLM, Aug 26 (Reuters) - Swedish radiation therapy equipment maker Elekta EKTAb.ST on Wednesday reported bigger-than-expected fiscal first-quarter profit despite a decline in sales due to the COVID-19 pandemic.
Operating profit jumped 42% from a year earlier to 335 million crowns ($38.21 million). Four analysts polled by Refinitiv had on average forecast a profit of 172 million crowns.
Profit before interest, tax and amortisation grew 23% to 551 million crowns.
($1 = 8.7668 Swedish crowns)
(Reporting by Anna Ringstrom, Editing by Supantha Mukherjee)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.